Circulation
-
Randomized Controlled Trial Multicenter Study
Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: 10-Year Follow-Up of a Randomized Controlled Trial.
The long-term efficacy and safety of low-dose aspirin for primary prevention of cardiovascular events in patients with type 2 diabetes mellitus are still inconclusive. ⋯ URL: http://www.clinicaltrials.gov. Unique identifier: NCT00110448.